NCT05698459 OH2 Oncolytic Viral Therapy Via Transcatheter Intraarterial Infusion in Patients with Advanced Liver Cancer Status RECRUITING Phase PHASE1
NCT05603039 A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma Status UNKNOWN Phase PHASE1/PHASE2
NCT04906434 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor Status RECRUITING Phase PHASE1
NCT04163237 Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer Status UNKNOWN Phase PHASE3
NCT03484962 Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer Status WITHDRAWN Phase PHASE2
NCT03474822 Plasmodium Immunotherapy for Breast and Liver Cancers Status RECRUITING Phase PHASE1/PHASE2
NCT03146637 Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer Status UNKNOWN Phase PHASE2
NCT02873442 Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT02862613 Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT01754987 A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective Status COMPLETED Phase PHASE1/PHASE2